Perspective Therapeutics, Inc. — Director's Dealing 2020

Feb 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2020-02-03

Reporting Person: Woods Lori A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common Stock	M	75000	$0.6050	Acquired	355000	Indirect
2020-02-03	Common Stock	M	125000	$0.46	Acquired	480000	Indirect
2020-02-03	Common Stock	M	62500	$0.43	Acquired	542500	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Stock Options (right to buy)	$0.6050	M	75000	Disposed	2027-06-27	Common Stock (75000)	Direct
2020-02-03	Stock Options (right to buy)	$0.46	M	125000	Disposed	2028-06-13	Common Stock (125000)	Direct
2020-02-03	Stock Options (right to buy)	$0.43	M	62500	Disposed	2029-06-18	Common Stock (62500)	Direct

Footnotes

F1: On January 27, 2020, 280,000 shares were transferred to the Woods Family Living Trust. These shares were previously reported on Form 4 filed November 19, 2019.

F2: 100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% will vest on 6/27/2020. The shares exercised on 2/3/2020 represent the shares that vested on 6/27/2017, 6/27/2018 and 6/27/2019.

F3: 250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, and the remaining 50% will vest over the next two (2) years, commencing on 6/13/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 12/13/2018 and 6/13/2019.

F4: 250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 6/18/2019.